квантовая медицина в онкологии
The cancer dairy железы now is most frequently meeting malignant новообразованием among women, with annually increasing parameters of desease [1]. Despite of the big popularity органосохраняющего treatments, his{its} application is limited to early stages of a cancer dairy железы with a tumour no more than 3 sm, absence clinically positive axillary лимфоузлов, the size dairy железы, localization of a tumour and a number{line} of other reasons [2]. The increase in number of local relapses and quite often unsatisfactory aesthetic results [3] also takes place. Also frequency of application органосохраняющего treatments depends on quality of diagnostics of early stages of disease in concrete medical institution. Therefore the basic type of radical intervention at a cancer dairy железы still is modified radical мастэктомия in updatings Маддена and a plenty of the patients who have transferred this operative мешательство, experience the significant psychological difficulties connected to loss dairy железы [4]. Подробнее...
Unresolved there is a question on optimum duration of chemotherapy of the first line. Today it is possible to recommend an individual approach in each concrete case. At a stage of chemotherapy of the first line it is necessary to aspire to achievement of full regress with disappearance of all displays of illness including normalization of level СА-125, and then to fix the achieved effect carrying out of 2-3 more additional rates. At achievement of partial regress it is necessary to continue chemotherapy till the moment when during two last rates stabilization of illness is marked, estimating on the sizes of residual tumoral weights and concentration of tumoral markers. By own experience I can tell, that in these cases at the majority of patients the number of courses of treatment will make from 6 up to 12, but not less than 6. In case of stabilization of illness it is necessary to limit volume of treatment by 6 rates after which end therapy can be stopped up to attributes of progressing or it is continued with use of modes of the second line depending on the general{common} condition of the patient and its{her} attitude{relation} to the further carrying out chemotherapy. At progressing illness it is necessary to pass to modes of the second line of chemotherapy. Подробнее...